Biogen downgraded to Hold from Buy at Stifel
February 21, 2019 at 08:47 AM EST
Stifel analyst Paul Matteis downgraded Biogen to Hold from Buy and lowered his price target for the shares to $346 from $397.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.